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Objectives. The aim of this study was to evaluate the perfor- 
mance of a new arterial biopsy catheter in obtaining pulmonary 
endovascular samples in a canine model. 
Background. Percutaneous endomyocardial biopsy is a widely 
used and valuable procedure in the management of posttrans- 
plant rejection and selected cardiomyopathies. A similar method 
of obtaining endoarterial biopsy samples would aid in the study, 
diagnosis and management of arterial diseases. 
Methods. Catheterization was performed in 19 dogs, each 
weighing 20 to 30 kg, through an 8F sheath in the external jugular 
vein to obtain pulmonary endoarterial samples. The catheter 
consists of two sliding tubes: an inner one with a beveled opening 
that accommodates ndoarterial tissue by means of a vacuum and 
an outer tube with a sharp distal edge that cuts the tissue when 
activated. 
Results. Overall, a total of 266 separate biopsy attempts were 
performed, and 161 tissue samples were obtained (success rate 
61%). With modifications in technique in the last nine dogs, 54 
(93%) of 58 attempts were successful. There were no deaths, 
extravasation of contrast material on angiography or thrombi. Of 
20 vessels with prebiopsy and postbiopsy angiograms, 1developed 
transient spasm (5%). On microscopic examination of cross 
sections of 50 separate pulmonary endoarterial biopsy samples, 
all had smooth muscle cells and 30 contained endothelial cells 
(60%). The arteries of origin showed small intimal and medial 
tears and mild perivascular hemorrhage. Angiographic and 
pathologic examination of previously biopsied arterial segments 2
weeks (two dogs) and 8 weeks (two dogs) after the procedure 
showed patent vessels and no thrombi. Histologically, the biopsy 
sites revealed mild neointimal and medial proliferation. 
Conclusions. This new endoarterial biopsy catheter is safe and 
effective in obtaining pulmonary artery samples in normotensive 
dogs. 
(JAm Coil Cardiol 1996;27:218-24) 
In 1962, Sakakibara nd Konno (1) reported the development 
of the bioptome catheter and a technique for intracardiac 
biopsy. Since then, transvenous endomyocardial biopsy has 
become awidespread and valuable procedure for the detection 
and grading of cardiac transplant rejection, diagnosis of myo- 
carditis, determination f doxorubicin cardiotoxicity and diag- 
nosis of specific infiltrative diseases, such as sarcoidosis, amy- 
loidosis and glycogen storage disease (2). A similar 
percutaneous method of obtaining arterial wall biopsy samples 
has not been described. Such a technique would facilitate the 
study, diagnosis, development of new treatment s rategies and 
monitoring of the evolution of arterial diseases. We describe a
new biopsy catheter designed to obtain endoarterial samples 
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and evaluate its performance in distal pulmonary arteries of 
normotensive dogs. 
Methods  
Study protocol. This study protocol was approved by the 
Animal Subjects Committee of the University of California 
San Diego, and the procedures followed were in accordance 
with institutional guidelines. Nineteen mongrel dogs weighing 
20 to 30 kg received 10 mg/kg body weight of intravenous 
propofol, underwent intubation and ventilation at a rate of 
12 breaths/rain and were maintained under anesthesia with 
1.5% halothane. A femoral artery line was placed for moni- 
toring. An 8F sheath was placed percutaneously in the external 
jugular vein, and a 7F endhole catheter (Arrow, Inc.) was 
advanced through this sheath to a distal lower lobe pul- 
monary artery, where pressures were recorded. An 0.038-in. 
(0.095 cm), 260-cm extrastiff Amplatz exchange guide wire 
(Meditech, Inc.) was passed through the end-hole catheter. 
The end-hole catheter was exchanged for an 8F Blue Mullins 
Introducer sheath (75 cm long) (Cook, Inc.) that was adapted 
with a radiopaque band at the distal end and shaped with a 
heat gun to conform to the right cardiopulmonary pathway. 
© 1996 by the American College of Cardiology 0735 - 1097/96/S 15.011 
0735- 11197(95)0t)422-X 
JACC Vol. 27, No. 1 ROTHMAN ET AL. 219 
Janua~' 1996:218-24 NEW ENDOARTERIAL BIOPSY CATHETER 
Figure 1. Endoarterial biopsy catheter procedural configuration. The 
biopsy catheter isconnected externally to a vacuum source consisting 
of two suction cannisters in series with a vacuum pump. The endoar- 
terial biopsy catheter is directed to a desired sampling site through a 
long 8F sheath, which is placed by percutaneous technique and 
advanced through the right heart into a distal pulmonary artery 
branch. 
Each dog was given 100 U/kg of heparin. A 7F Berman 
angiographic catheter (Arrow, Inc.) was advanced through the 
sheath into a 2.5- to 3.0-mm distal pulmonary artery branch, 
where an angiogram was obtained. The angiographic catheter 
served as a guide to advance the stiff sheath into a small vessel 
targeted for biopsy and was then exchanged for the endoarte- 
rial biopsy catheter (Fig. 1). In the first four dogs, we also 
performed endoarterial biopsies of the left carotid artery 
under direct vision. 
Endoarterial biopsy catheter. The catheter has an external 
diameter of 2.5 mm (7.9F) and is composed of two flexible 
polymeric tubes that slide relative to each other. The inner 
tube has a stainless teel distal end with a beveled opening that 
is designed to accommodate arterial tissue. A vacuum is 
coupled to the inner tube and channeled to the beveled 
opening. The outer tube terminates in a stainless teel cutting 
tube. The proximal ends of the two tubes are fitted with 
handles. To obtain the biopsy sample, a vacuum is transmitted 
to the beveled opening of the inner tube, causing a tissue 
sample to be drawn in. The outer tube is then advanced over 
the inner tube, severing the tissue sample (Fig. 2). The beveled 
opening is formed by the intersection of a proximal end surface 
that is perpendicular to the long axis of the catheter tip and a 
distal beveled surface situated at an angle to the catheter tip 
(Fig. 3). With this design, the area of artery contacted by the 
outer periphery of the beveled opening is larger than the inner 
aperture connected to the vacuum, thus maintaining the tissue 
sample with its orientation preserved. 
A variety of beveled window sizes were tested for their 
ability to transmit he vacuum and preserve the tissue samples. 
If the size of the beveled opening was <1.0 mm in the axis 
parallel to the long axis of the catheter, vacuum transmission 
was inadequate for biopsy sampling. Therefore, subsequent 
catheters were manufactured with a beveled opening long axis 
dimension >1.0 ram. 
The amount of vacuum required to draw in pulmonary 
(A) 
(c )  
(D) 
Figure 2. Schematic representation f the biopsy sampling procedure. 
The distal end of the catheter isshown extending from the distal end 
of the radiopaque-tipped introducer sheath, with the outer tube 
covering the beveled opening of the inner tube (A). The outer tube is 
retracted, exposing the inner tube (B). On vacuum transmission 
through the inner tube, an endoarterial tissue sample is drawn into the 
beveled opening (C). The outer tube is advanced over the inner tube, 
severing the tissue sample (D). 
artery tissue samples and allow cutting by the outer tube is 
determined by the ultimate vacuum of the vacuum source, the 
narrowest opening in the vacuum transmittance pathway and 
the vacuum differential between the open and closed configu- 
rations of the beveled window. In our study, the source of the 
vacuum was a two-stage rotary vane vacuum pump (Dayton 
Electrical Mfg. Co.) that could achieve an ultimate vacuum of 
29.9 in. Hg. To obtain pulmonary endoarterial samples reliably 
in these normal dogs, a differential of at least 2 in. Hg in 
vacuum (open versus closed beveled window) was required. If 
the internal diameter of the inner catheter tube was <1.0 mm, 
this difference in vacuum could not be attained. Subsequent 
Figure 3. Configuration of the distal catheter. Top (left) and side 
(right) views of the beveled opening in the distal metal tip of the inner 
catheter tube. 
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catheters were made with an inner tube internal dimension of 
1.3 man. These catheters could pull -26.5 in. Hg of vacuum 
with the beveled window open and 29.0 in. Hg of vacuum with 
the beveled window closed, giving a vacuum differential of 
2.5 in. Hg. 
Procedure. To perform the biopsy procedure, the stiff 
sheath was wedged into a small distal pulmonary artery branch, 
and multiple biopsy samples were obtained. After each biopsy, 
the catheter was removed and the tissue specimen placed in 
either formalin for histologic examination or appropriate 
culture media. To stimulate smooth muscle cell growth, sam- 
ples were placed in media 199 (Gibco) + 20% fetal calf serum, 
2 retool/liter L-glutamine, penicillin and streptomicin. To stim- 
ulate endothelial cell growth, separate samples were placed in 
endothelial cell basal and growth media (Clonetics). 
After the biopsy procedures were completed, repeat angio- 
grams were obtained to assess the degree of vascular injury, 
including the presence of thrombus, vascular occlusion, extrav- 
asation of contrast material or aneurysm formation. 
Acute study. In the acute experiments, 13 dogs were eu- 
thanized immediately after the biopsy procedure. The lungs 
were examined grossly from the external surface, and the 
pulmonary arteries were then dissected and examined with 
specific attention to the sites of sheath manipulation and 
biopsy. The biopsied arterial segments were excised and placed 
in formalin for histologic examination. 
Chronic study. In the chronic experiments, ix dogs were 
allowed to recover after the biopsy procedure. Two dogs at 2 
weeks and two dogs at 8 weeks underwent repeat angiography, 
followed by euthanasia and histologic examination as previ- 
ously described. Two dogs are doing well clinically and are still 
under study 6 months after the biopsy procedure. 
Resu l ts  
Success rate. The 19 dogs underwent a total of 266 sepa- 
rate biopsy attempts. Of these, 161 yielded pulmonary endo- 
arterial samples (success rate 61%). After the experiments in
the first four animals, the technique was modified, leading to 
improved sample retrieval rates: 124 (70%) of 177 biopsy 
attempts in the next 15 dogs and 54 (93%) of 58 biopsy 
attempts in the last 9 dogs. 
Effects of biopsy procedure. Introduction of the stiff guide 
wire and stiff sheath through the right heart caused small or no 
changes in systemic blood pressure and occasional premature 
ventricular beats. Once the sheath was in good position, 
passage of the biopsy catheter, sampling of the artery and 
removal of the biopsy catheter (leaving the sheath in place) did 
not cause changes in systemic blood pressure or cardiac 
rhythm. 
All dogs in these xperiments had normal pulmonary artery 
pressure (<25 mm Hg systolic), The prebiopsy angiograms of 
distal right (Fig. 4) or left lower lobe branches showed smooth 
vessels with uniform branching, a normal capillary cycle time 
and brisk venous return to the left atrium. Twenty separate 
arteries had adequate prebiopsy and postbiopsy angiographic 
Figure 4. Pulmonary artery angiograms before and after the biopsy 
procedure. Distal right lower lobe branch pulmonary artery angiogram 
before biopsy depicting the target sampling site (arrowheads, top left). 
A radiopaque marker denotes the distal end of the guiding sheath 
through which the catheter is deployed in the open position (top right). 
At biopsy, the catheter is in the closed position (bottom left). Imme- 
diately after biopsy, the sampled artery is patent (arrowhead), without 
evidence of contrast extravasation (bottom right). 
results for analysis. Of these, one vessel (5%) on the postbiopsy 
angiogram was initially occluded but opened toward the end of 
the contrast injection, suggesting the presence of transient 
spasm. Another seven arteries developed irregular vessel wall 
contours on postbiopsy angiography but retained brisk flow. 
The other 12 vessels maintained intact appearance and flow on 
postbiopsy angiography. No instances of contrast extravasation 
into pulmonary parenchymal tissue were observed, even in one 
dog that underwent 11 consecutive biopsies in the same distal 
pulmonary artery branch. 
Because the vacuum is connected totwo reservoirs in series, 
we could quantitate the amount of blood that returned when 
the vacuum was applied. In the first four dogs, the guiding 
sheath was not wedged into the artery that was being biopsied, 
and there was a large amount of blood loss into the vacuum 
traps. With wedging of the sheath during the biopsy in each of 
the last 15 experiments, there was <10 ml of blood in the 
proximal trap at the end of the biopsy procedure. 
Pathologic examination. Surgically exposed carotid arter- 
ies were examined uring biopsy attempts under direct vision. 
If the size of the beveled opening was < 1.6 ram, on vacuum 
application asmall external dimple formed in the artery at the 
site of the window. With larger hole sizes, there was complete 
invagination of the artery into the beveled opening. Regardless 
of the size of the beveled opening (maximum 2.2 ram), we did 
not observe a breech in the outer layer of the artery after 
biopsy, even after 12 attempts at the same site. 
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Figure 5. Pulmonary endoarterial biopsy sample. He- 
matoxylin and eosin staining ×100. Bar = 100/xm. 
In the dogs that underwent pulmonary artery biopsy, gross 
examination of the surface regions of the lungs from which 
biopsy samples were obtained did not reveal evidence of 
external injury. Postmortem dissection of the pulmonary artery 
tree, from the main pulmonary artery to the small peripheral 
arteries in all lobes, revealed absence of thrombi in the vessels 
that were biopsied and in the neighboring pulmonary arteries. 
Fifty biopsy samples were subjected to microscopic exami- 
nation. All were composed predominantly of smooth muscle 
cells (Fig. 5); 30 contained endothelial cells (60%) (Fig. 6), and 
one had a thin layer of adventitia. At the sites of arterial 
biopsy, tears in the intima and part or all of the media were 
observed (Fig. 7). In rare samples, the tear extended to the 
inner layers of the adventitia. Perivascular bleeding was seen 
frequently on acute histologic examination but was negligible 
or limited in size in arteries that had undergone fewer than 
four biopsies and more extensive in arteries that had under- 
gone multiple biopsy samplings. 
Cell culture. Smooth muscle cells grew quickly in 24 of 24 
attempts, were easily passaged and stained uniformly with 
anti-smooth muscle myosin antibodies. In the endothelial 
growth media, endothelial cells were identified in 4 of 27 
attempts. Primary cultures were composed of a mixture of 
endothelial cell islands and fibroblasts. However, after the first 
subculture, the endothelial cells were outcompeted and over- 
grown by the fibroblasts. 
Chronic study. In the chronic study, the six dogs recovered 
from the biopsy procedure and anesthesia without complica- 
tion. None of the animals developed a cough, tachypnea or 
respiratory distress immediately after the biopsy or during the 
follow-up period. Two dogs are doing well clinically 6 months 
after the biopsy procedure. 
Follow-up angiography was performed 2weeks (two dogs) 
or 8 weeks (four dogs) after biopsy. There was no evidence of 
thrombus, vascular occlusion or aneurysm formation. Six ves- 
sels had good quality postbiopsy and follow-up angiograms for 
comparison. Three had irregular vascular wall contours at the 
biopsy site, and three had visually normal vessel walls imme- 
diately after the procedure. All six arteries had smooth vascu- 
lar contours at follow-up angiography 2 weeks (two vessels) or 
2 months (four vessels) after biopsy. 
In the four dogs that were euthanized, the arterial biopsy 
sites were difficult to identify by gross pathologic examination 
because uniform healing had occurred. Histologically, the 
arterial sites that had been previously biopsied showed mild 
neointimal proliferation and no perivascular hemorrhage 
(Fig. 8). 
Figure 6. Enlarged view of biopsy sample. A layer of 
endothelial cells is shown on the lumen surface of the 
internal elastic lamina (arrowheads). Hematoxylin 
and eosin staining x200, reduced by 35%. 
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Figure 7. Pulmonary artery site immediately after 
biopsy procedure. The vascular wall disruption (ar- 
rowhead) extends through part of the media, but the 
adventitia s intact. Hematoxylin and eosin staining 
xl00, reduced by 35%. 
Discuss ion 
Pulmonary hypertension is an inexorably progressive dis- 
ease with imperfect therapeutic options and a high mortality 
rate (3,4). Other diseases that affect the arterial system, 
including systemic hypertension (5), polyarteritis nodosa, 
Wegener's granulomatosis, necrotizing vasculitis (6-8), Taka- 
yasu's arteritis (9), Kawasaki disease (10), vascular neoplasms 
(11), transplantation arteriopathy (12) and Williams syndrome 
(13) may also cause significant morbidity and mortality, yet 
their etiology, pathophysiologic mechanism and optimal ther- 
apy are still unclear. 
Progress in the understanding, diagnosis and management 
of arterial diseases has been limited in part by the inaccessi- 
bility of tissue for examination and experimentation. Percuta- 
neous removal of smooth muscle cells from coronary and 
peripheral vascular lesions has been reported (14-18) using a 
directional atherectomy catheter. However, with this method 
the yield of smooth muscle cells has frequently been insuffi- 
cient for further studies (14,16), and the mechanism of sample 
procurement is best suited to obtain material from arteries 
with atheromatous lesions protruding into the vascular lumen 
rather than arteries with smooth internal surfaces. Because we 
have a special interest in the study of pulmonary vascular 
disease, our aim in this project was to evaluate the efficacy and 
safety of a new endoarterial biopsy catheter in obtaining tissue 
samples from peripheral pulmonary arteries. However, minor 
modifications in the technique should make the procedure 
applicable to systemic arteries. By procuring endoarterial 
samples, this method should also be particularly useful in 
assessing the results of direct drug delivery to the vessel wall 
(19-21), gene therapy for cardiovascular diseases (22-27) and 
seeding of the vasculature with cells that have been previously 
removed from arteries and genetically modified in vitro 
(28,29). 
Catheter design. In contrast o obtaining an endomyocar- 
dial biopsy, where the tissue to be sampled is generally 
perpendicular to the biopsy catheter, for an endoarterial 
biopsy the tissue to be sampled is generally in parallel with the 
Figure 8. Pulmonary. artery sampling site 2 months 
after biopsy procedure. The sampling site shows mild 
localized neointimal hyperplasia (large arrowhead) 
compared with the normal adjacent artery wall 
(small arrowheads). Hematoxylin a d eosin staining 
xl00, reduced by 35%. 
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catheter. The difficulty in generating mechanical force to 
obtain vascular wall samples in a radial orientation to the 
catheter made the use of a vacuum particularly suitable for this 
purpose. Hence, the inner tube of the catheter became the 
dedicated conduit for the vacuum. In addition, the catheter 
was primarily made of flexible polymeric tubes to negotiate the 
pathways of the cardiovascular system. Rigid distal ends were 
attached to both inner and outer tubes to facilitate cutting of 
the endovascular tissue. 
Technique. We found it easier to advance the large and 
stiff sheath through the right heart of the dogs from an external 
jugular venous approach rather than from the femoral veins. 
The use of an 0.038-in. extrastiff guide wire followed by a long, 
stiff 8F sheath facilitated placement of the biopsy catheter 
through the right heart o distal right or left pulmonary artery 
branches. Maintenance of the sheath in the target vessel 
expedited the repeated sampling attempts. 
During preliminary attempts to obtain biopsy samples, the 
endoarterial biopsy catheter was placed in relatively large 
pulmonary vessels. On application of the vacuum, there was an 
unpredictable amount of blood loss, depending on the degree 
of tissue lodging on the beveled window. To minimize the 
amount of blood loss and ensure better suctioning of endoar- 
terial tissue into the beveled window, we modified the tech- 
nique to wedge the guiding sheath during biopsy attempts in 
distal pulmonary arteries. In this position, when the vacuum 
was applied, there was no significant return of blood through 
the inner catheter tube, and the success rate of the procedure 
increased (93% in the last nine dogs). However, with this 
method there were instances where the sheath remained 
wedged between biopsy attempts and air became trapped in 
the sheath on removal of the biopsy catheter. Attempts to pull 
back the sheath to remove the air sometimes resulted in sheath 
kinking. To minimize this problem, the technique was refined 
to partially wedge the sheath initially, advance the sheath just 
before biopsy and retract he sheath immediately after sam- 
pling but before biopsy catheter removal. 
Passage of the biopsy catheter through the curved stiff 
sheath in the right heart was facilitated by keeping the catheter 
in the closed position (shortening the total metal tip length at 
the distal end of the catheter). The addition of a radiopaque 
marker to the end of the sheath aided in guiding the sheath to 
the desired position in the vasculature. This change helped 
optimize success of the biopsy procedure and minimize sheath- 
related complications in small distal pulmonary arteries. To 
reduce the possibility of small endoarterial biopsy samples 
from being suctioned into the vacuum trap, the vacuum was 
turned off immediately after the outer cutting tube was ad- 
vanced over the inner tube. 
Biopsy samples. Biopsy studies were performed in normo- 
tensive dogs. The thickness of the pulmonary artery wall in the 
vicinity of the biopsy sites was very thin. Therefore, some of the 
samples that were obtained were also thin and elongated. We 
speculate that larger pieces will be retrieved from thickened 
and chronically hypertensive arterial walls. 
The paucity of endothelial cells in some biopsy samples can 
partly be explained by the probable trauma of excessive 
manipulation of the guiding sheath and biopsy catheter and 
frequently obtaining multiple biopsies at the same site. In 
addition, the orientation of the cross section during specimen 
processing could yield variable numbers of endothelial cells on 
microscopic examination. To maximize the yield of endothelial 
cells, the first biopsy sample should be obtained proximally in 
the target vessel, with subsequent samples obtained progres- 
sively more distally in the same or other arteries. 
Vascular adventitia was seen rarely on microscopic ross 
sections of the biopsy samples. On histologic examination of
the biopsied arteries, the endovascular tissue removed by the 
biopsy catheter infrequently extended into the adventitial 
layer, probably due to the high content of connective tissue in 
the adventitia, which provides a rigid and resistant layer. 
Additionally, cutting in an axis parallel to the vessel is relatively 
ineffective compared with perpendicular cutting. Our proce- 
dure also uses manual cutting, which is relatively slow, allowing 
the vessel time to recoil. Perhaps because of a combination of
these factors, the adventitial layer was not breeched in any of 
the biopsy attempts, even when the vessel was entirely invag- 
inated in the beveled window during carotid artery attempts 
under direct vision. 
Complications. There were no significant complications 
related to the biopsy procedure. No animal died as a result of 
the procedure. Changes in blood pressure or cardiac rhythm 
were minimal and transient during manipulations of the stiff 
sheath and during the actual biopsy sampling. The amount of 
blood loss as a result of the vacuum was negligible when the 
guiding sheath was properly wedged. Angiography performed 
immediately after vessels were biopsied revealed no thrombi, 
aneurysms or extravasation. One vessel was completely ob- 
structed at the beginning of the contrast injection but abruptly 
reestablished flow toward the end of the selective arterial 
injection. We presume that this was a transient spasm because 
no thrombus was found at autopsy 1h later. One-third of the 
vessels that were biopsied showed an irregular vascular con- 
tour on postbiopsy angiography that was probably due to a 
combination ofpartial vessel spasm and intimal flaps and tears. 
Gross pathologic examination of the pulmonary lobe sub- 
jected to biopsy revealed no surface evidence of injury. On 
microscopic examination of arteries obtained immediately 
after biopsy, there was a small accumulation of periarterial 
blood that seemed to increase with the number of biopsy 
attempts at a single site. The source of blood could be 
secondary to tracking along disruptions of the endovascular 
wall or perhaps due to rupture of the vasa vasorum. 
Angiography of six arteries 2 to 8 weeks after biopsy 
demonstrated patent vessels with smooth vascular contours, 
including three arteries that had irregular lumen borders 
immediately after biopsy. Gross examination of the arterial 
biopsy sites revealed no identifiable areas of injury. Microscop- 
ically, the perivascular bleeding had resolved, and there were 
occasional regions of mild neointimal hyperplasia that were 
presumed to correspond to the previous biopsy sites. There- 
fore, the biopsied pulmonary vessels in these dogs demon- 
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strated a prompt and complete healing response within 2 
months of the biopsy procedure. 
Limitations of the study. The present study has several 
limitations. The success and safety of the endoarterial biopsy 
catheter at normal pulmonary artery pressures does not ensure 
similar results at high pressures. Diminished elasticity of 
thickened and diseased vessels may limit the ability of the 
vacuum to pull tissue into the beveled window. Also, vascular 
disruptions after biopsy may be more prone to extravasation f
blood at higher pressures. Other limitations include the size of 
arteries that can be biopsied with a specific sheath size. The 8F 
long sheath and 7.9F biopsy catheter that were used in this 
study are too large to use in small animals or infants. An 
additional imitation is that the canine pulmonary artery 
endothelial cells in culture appear to grow with difficulty and 
are quickly outcompeted by fibroblasts. However, modifica- 
tions in the catheter, technique and laboratory methods should 
be able to overcome the majority of these limitations. 
Conclusions, The present study describes a new biopsy 
catheter that appears to be effective and safe in procuring 
endoarterial samples from distal pulmonary arteries of normo- 
tensive dogs. With minor modifications in technique, this 
catheter should be suitable for sampling of hypertensive pul- 
monary arteries as well as systemic arteries. Potential future 
uses include its application as a diagnostic and research tool 
for inflammatory, genetic, atherosclerotic and idiopathic vas- 
cular diseases; posttransplantation arteriopathy; and the eval- 
uation of localized drug delivery and gene therapy for cardio- 
vascular diseases. 
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